Inventor

WANG GUANGYANG

CN9 patents

⚠️ This page may combine multiple inventors who share the name “WANG GUANGYANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CSMC TECHNOLOGIES FAB2 CO LTD

3 patents

US11088132B2Aug 10, 2021

Semiconductor device for enhancing electrostatic discharge protection and layout structure thereof

CSMC TECHNOLOGIES FAB2 CO LTD0 citations59

US10381343B2Aug 13, 2019

Electrostatic protection device of LDMOS silicon controlled structure

CSMC TECHNOLOGIES FAB2 CO LTD0 citations50

US11264468B2Mar 1, 2022

Semiconductor device

CSMC TECHNOLOGIES FAB2 CO LTD0 citations49

CALIFORNIA INST OF TECHN

2 patents

US6284163B1Sep 4, 2001

Sol-gel encapsulation of lipid vesicles, lipid membranes and proteins

CALIFORNIA INST OF TECHN10 citations71

US6767483B2Jul 27, 2004

Sol-gel encapsulation of lipid vesicles, lipid membranes and proteins

CALIFORNIA INST OF TECHN1 citations50

CSMC TECHNOLOGIES FAB1 CO LTD

2 patents

US9780084B2Oct 3, 2017

Electrostatic discharge protection structure and fabrication method thereof

CSMC TECHNOLOGIES FAB1 CO LTD0 citations45

US9343454B2May 17, 2016

Electrostatic discharge protection structure and fabrication method thereof

CSMC TECHNOLOGIES FAB1 CO LTD0 citations45

TIBOTEC PHARM LTD

1 patent

US6649651B1Nov 18, 2003

Hexahydrofuro[2,3-B]furan-3-yl-n{3[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

TIBOTEC PHARM LTD18 citations89

US HEALTH

1 patent

US7157495B2Jan 2, 2007

Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

US HEALTH6 citations71